Top Buy
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €124.20 | €130.00 | 4.670% |
| Novartis AG ADR | 1 | 0 | 0 | 0 | €90.40 | - | - |
| Ipsen S.A. | 1 | 0 | 0 | 0 | €115.40 | €109.00 | -5.546% |
| GSK plc | 1 | 0 | 0 | 0 | €20.21 | - | - |
| AstraZeneca plc | 1 | 0 | 0 | 0 | €141.15 | €165.00 | 16.897% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €189.00 | - | - |
| Koninklijke Philips Electronics ADR | 2 | 1 | 0 | 0 | €24.40 | - | - |
| Koninklijke Philips Electronics | 2 | 0 | 1 | 0 | €25.01 | - | - |
| Smith & Nephew plc ADR | 2 | 0 | 0 | 0 | €22.60 | - | - |
| UCB S.A. | 2 | 0 | 0 | 0 | €120.70 | - | - |
| EssilorLuxottica SA | 3 | 0 | 0 | 0 | €202.40 | €204.50 | 1.038% |
| Sanofi S.A. | 4 | 0 | 0 | 0 | €91.03 | €99.50 | 9.305% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| Fresenius SE & Co. KGaA | 4 | 0 | 1 | 0 | €27.98 | - | - |
| Quest Diagnostics Inc. | 4 | 0 | 1 | 0 | €127.10 | €144.44 | 13.646% |
| Fresenius Medical Care AG & Co KGaA ADR | 4 | 1 | 2 | 0 | €20.20 | €21.00 | 3.960% |
| GSK plc ADR | 4 | 0 | 0 | 0 | €40.60 | - | - |
| Fresenius Medical Care AG & Co KGaA ST | 6 | 0 | 0 | 0 | €39.19 | €48.50 | 23.756% |
| Becton, Dickinson & Co. | 8 | 0 | 0 | 0 | €218.00 | €262.02 | 20.194% |
| Universal Health Services B | 9 | 3 | 1 | 1 | €156.00 | €159.70 | 2.375% |
| Teleflex Inc. | 10 | 0 | 0 | 0 | €189.00 | €247.18 | 30.783% |
| Medtronic plc | 10 | 1 | 0 | 0 | €75.89 | €93.46 | 23.146% |
| Idexx Laboratories Inc. | 11 | 0 | 2 | 0 | €446.50 | €552.72 | 23.789% |
| Laboratory Corp. Of America (labcorp) | 11 | 0 | 2 | 0 | €188.00 | €237.94 | 26.564% |
| Henry Schein Inc. | 11 | 1 | 0 | 0 | €62.96 | €79.30 | 25.954% |